Erin Hunter, Assistant Editor

Link between male or female sex and the severity of COVID-19 may be found in a subset of regulatory T cells.

More than 90 minutes of varied sleep time may also increase a person’s risk of developing hardened arteries.

New data identifying a particular gene expression signature will be presented at the 2023 ASCO Genitourinary Symposium.

Data from 52 studies show that antimicrobial stewardship programs largely reduced antibiotic use for pediatric care.

Those seeking abortion were found to have triple the risk of a psychiatric disorder compared to the general population.

Idecabtagene vicleucel prolonged progression-free survival by more than 1 year in a difficult-to-treat patient population with relapsed or refractory multiple myeloma.

Analysis shows average monthly premiums for stand-alone plans will rise 10% to $43.

Relative efficacy of nirmatrelvir–ritonavir appears similar across risk groups, but older adults at risk of severe COVID-19 may benefit more.

Streptolysin O appears to influence the pathogenesis of Streptococcus group A and direct mutation-mediated virulence in a host.

Low cognitive functioning and cognitive decline have been linked to an increased risk of morbidity and mortality.

New guidance provides recommendations on infection prevention strategies, performance measures, and how to implement these approaches.

A booster vaccine for COVID-19 increased the concentration of antibodies in older patients more than younger patients.

Several studies have noted a potential link between methotrexate and an increased risk of skin cancer.

Long COVID can impact quality of life, with some symptoms lasting for 1 year before the patient recovers to baseline.

Cancer screening rates were still below the expected rates of return in both 2021 and 2022.

Multiple adverse outcomes were associated with an even higher risk of heart disease.

Investigators hope that new findings can cultivate new methods of facilitating immune response to attack lung tumors.

Paroxysmal nocturnal hemoglobinuria is a rare and life-threatening blood condition.

JNJ-80202135 (nipocalimab) treats hemolytic disease of the fetus and newborn caused by maternal red blood cells.

The vaccine has robust effects for multiple serotypes of pneumococcal disease.

On February 6, 2023, Pharmacy Times also learned that the FDA just accepted a new drug application (NDA) for this treatment.

One hypothesis suggest that our environment is too sterile.

Migraine could be considered a clinical marker of increased obstetric risk in pregnant women.

Bone marrow transplant could effectively change the brain’s blood vessels from abnormally narrowing.

The economic burden of symptoms of major depressive disorder were estimated to cost $326 billion for the United States in 2018 alone.

The approval is for the youngest patient population with hereditary angioedema to date.

Ultra-processed food consumption linked to an increased risk of developing and dying from ovarian cancer and breast cancer.

Participants also generally prefer newer injectable pre-exposure prophylaxis compared to pills for HIV prevention.

The CBD gummy market is being fueled by the desire for alternative, natural treatment options.

Results from the phase 2 and long-term trials will be presented later this year, following further data collection.